Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Advanced Medical Optics, a developer of advanced refractive technologies for eye care professionals and patients, has received the FDA approval for its Tecnis multifocal intraocular lens for cataract patients.
Subscribe to our email newsletter
Advanced Medical Optics’s (AMO) Tecnis multifocal intraocular lens (IOL) are indicated for primary implantation for the visual correction of aphakia in adult patients with and without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire near, intermediate, and distance vision with increased spectacle independence. AMO plans to ship Tecnis multifocal IOL to US surgeons in early 2009.
According to the company, the Tecnis multifocal IOL’s unique design gives patients superior near vision and reading speed compared to other presbyopia-correcting IOLs, as well as exceptionally high spectacle independence.
Jim Mazzo, chairman and CEO of AMO, said: “The introduction of the Tecnis multifocal IOL in the US rounds out AMO’s portfolio of refractive technologies. Following years of success in Europe, US surgeons will soon be able to pass the benefits of this technology on to their patients.”